Even if it's not a huge purchase, we think it was good to see that Alexander Waislitz, a Microba Life Sciences Limited (ASX:MAP) insider, recently shelled out AU$126k to buy stock, at AU$0.32 per ...

The analysts covering Microba Life Sciences Limited (ASX:MAP) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue ...

BRISBANE, Australia--(BUSINESS WIRE)--$MAP--Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is an Australian-based commercial stage ...

BRISBANE, Australia--(BUSINESS WIRE)--Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is excited to announce it has identified three therapeutic leads for the Company’s ...

Australian gut health startup Microba has been using the Google Cloud Platform (GCP) to gain a deeper understanding of customers' gut microbiome. According to Microba, the gut microbiome plays a ...

A next generation human gut microbiome testing product range called MetaXplore™ has been launched in Australia to healthcare professionals. The MetaXplore™ range provides diagnostic gastrointestinal ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Partnership will leverage Ginkgo's high throughput screening capabilities to identify potential therapeutic candidates for autoimmune diseases in Microba's extensive strain bank BRISBANE, Australia ...

Experts in gut microbiome analysis, Microba Life Sciences, is empowering global consumer goods company Unilever to take a novel approach to this problem by exploring the links between sleep and the ...

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results 41.9% tested positive for abnormal microbiome markers linked to gastrointestinal health 9.9% tested positive for ...

Appointment of Professor Trent Munro as Senior Vice President of Therapeutics. Professor Munro has over 25 years’ research and development experience, including with multinational biopharmaceutical ...

Leaders in precision gut microbiome science Microba Life Sciences has united with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, to advance ...